🟢 Moleculin Biotech is trading 5.9% up in pre-market — no clear catalyst identified

Moleculin Biotech is trading at $0.39, up 5.94%, in pre-market, with no clear company-specific catalyst identified.

• The company’s press-release page lists its October 7 conference announcement as its latest release, with no October 16 announcement shown.
• Shares closed at $0.37 on October 15 after a sharp decline; available information does not establish why they are rebounding.
• Broader pre-market indices are only modestly higher, so the move cannot be confidently attributed to the overall market.